Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1952 2
1953 1
1955 1
1956 3
1957 6
1958 8
1959 5
1960 5
1961 3
1962 6
1963 3
1964 10
1965 9
1966 19
1967 11
1968 19
1969 5
1970 14
1971 11
1972 14
1973 15
1974 17
1975 16
1976 11
1977 18
1978 7
1979 16
1980 18
1981 17
1982 19
1983 31
1984 41
1985 29
1986 29
1987 41
1988 40
1989 33
1990 34
1991 31
1992 32
1993 33
1994 32
1995 50
1996 34
1997 33
1998 31
1999 42
2000 21
2001 41
2002 36
2003 46
2004 40
2005 59
2006 61
2007 68
2008 53
2009 60
2010 58
2011 65
2012 68
2013 74
2014 80
2015 66
2016 60
2017 66
2018 69
2019 61
2020 57
2021 49
2022 41
2023 39
2024 25

Text availability

Article attribute

Article type

Publication date

Search Results

2,103 results

Results by year

Filters applied: . Clear all
Page 1
Vaccination and allergy: EAACI position paper, practical aspects.
Nilsson L, Brockow K, Alm J, Cardona V, Caubet JC, Gomes E, Jenmalm MC, Lau S, Netterlid E, Schwarze J, Sheikh A, Storsaeter J, Skevaki C, Terreehorst I, Zanoni G. Nilsson L, et al. Pediatr Allergy Immunol. 2017 Nov;28(7):628-640. doi: 10.1111/pai.12762. Epub 2017 Oct 10. Pediatr Allergy Immunol. 2017. PMID: 28779496 Free article. Review.
Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib.
Mesa R, Verstovsek S, Platzbecker U, Gupta V, Lavie D, Giraldo P, Recher C, Kiladjian JJ, Oh ST, Gerds AT, Devos T, Passamonti F, Vannucchi AM, Egyed M, Lech-Maranda E, Pluta A, Nilsson L, Shimoda K, McLornan D, Kawashima J, Klencke B, Huang M, Strouse B, Harrison C. Mesa R, et al. Among authors: nilsson l. Haematologica. 2024 Feb 1;109(2):676-681. doi: 10.3324/haematol.2023.283106. Haematologica. 2024. PMID: 37259556 Free PMC article. No abstract available.
A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q.
Fenaux P, Giagounidis A, Selleslag D, Beyne-Rauzy O, Mufti G, Mittelman M, Muus P, Te Boekhorst P, Sanz G, Del Cañizo C, Guerci-Bresler A, Nilsson L, Platzbecker U, Lübbert M, Quesnel B, Cazzola M, Ganser A, Bowen D, Schlegelberger B, Aul C, Knight R, Francis J, Fu T, Hellström-Lindberg E; MDS-004 Lenalidomide del5q Study Group. Fenaux P, et al. Among authors: nilsson l. Blood. 2011 Oct 6;118(14):3765-76. doi: 10.1182/blood-2011-01-330126. Epub 2011 Jul 13. Blood. 2011. PMID: 21753188 Free article. Clinical Trial.
Editorial.
Nilsson LG, Zhang K. Nilsson LG, et al. Psych J. 2012 Jun;1(1):1. doi: 10.1002/pchj.7. Psych J. 2012. PMID: 26272663 No abstract available.
Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation.
Tobiasson M, Pandzic T, Illman J, Nilsson L, Weström S, Ejerblad E, Olesen G, Björklund A, Olsnes Kittang A, Werlenius O, Lorentz F, Rasmussen B, Cammenga J, Weber D, Lindholm C, Wiggh J, Dimitriou M, Moen AE, Yip Lundström L, von Bahr L, Baltzer-Sollander K, Jädersten M, Kytölä S, Walldin G, Ljungman P, Groenbaek K, Mielke S, Jacobsen SEW, Ebeling F, Cavelier L, Smidstrup Friis L, Dybedal I, Hellström-Lindberg E. Tobiasson M, et al. Among authors: nilsson l. J Clin Oncol. 2024 Apr 20;42(12):1378-1390. doi: 10.1200/JCO.23.01159. Epub 2024 Jan 17. J Clin Oncol. 2024. PMID: 38232336
Response Letter to the editor.
Grossmann B, Nilsson A, Sjöberg F, Bernfort L, Nilsson L. Grossmann B, et al. Among authors: nilsson l. Acta Anaesthesiol Scand. 2021 Feb;65(2):279-280. doi: 10.1111/aas.13761. Epub 2020 Dec 16. Acta Anaesthesiol Scand. 2021. PMID: 33296499 Free PMC article. No abstract available.
Biomolecular dynamics in the 21st century.
Brooks CL 3rd, MacKerell AD Jr, Post CB, Nilsson L. Brooks CL 3rd, et al. Among authors: nilsson l. Biochim Biophys Acta Gen Subj. 2024 Feb;1868(2):130534. doi: 10.1016/j.bbagen.2023.130534. Epub 2023 Dec 6. Biochim Biophys Acta Gen Subj. 2024. PMID: 38065235 Free article. Review.
Understanding and overcoming obstacles in adaptive management.
Månsson J, Eriksson L, Hodgson I, Elmberg J, Bunnefeld N, Hessel R, Johansson M, Liljebäck N, Nilsson L, Olsson C, Pärt T, Sandström C, Tombre I, Redpath SM. Månsson J, et al. Among authors: nilsson l. Trends Ecol Evol. 2023 Jan;38(1):55-71. doi: 10.1016/j.tree.2022.08.009. Epub 2022 Oct 3. Trends Ecol Evol. 2023. PMID: 36202636 Free article. Review.
Dissecting the genetic landscape of GPCR signaling through phenotypic profiling in C. elegans.
Pu L, Wang J, Lu Q, Nilsson L, Philbrook A, Pandey A, Zhao L, Schendel RV, Koh A, Peres TV, Hashi WH, Myint SL, Williams C, Gilthorpe JD, Wai SN, Brown A, Tijsterman M, Sengupta P, Henriksson J, Chen C. Pu L, et al. Among authors: nilsson l. Nat Commun. 2023 Dec 18;14(1):8410. doi: 10.1038/s41467-023-44177-z. Nat Commun. 2023. PMID: 38110404 Free PMC article.
Antimicrobial β-peptides and α-peptoids.
Godballe T, Nilsson LL, Petersen PD, Jenssen H. Godballe T, et al. Among authors: nilsson ll. Chem Biol Drug Des. 2011 Feb;77(2):107-16. doi: 10.1111/j.1747-0285.2010.01067.x. Chem Biol Drug Des. 2011. PMID: 21266014 Review.
2,103 results